基本信息
views: 9
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Gladman’s research activities span both clinical and translational research with a focus on Psoriatic Arthritis (PsA) and Systemic Lupus Erythematosus (SLE). The PsA Program comprises a web-based database which includes 1600 patients with PsA, as well as 700 patients with psoriasis without arthritis. Using this extensive database, Dr. Gladman has carried out studies looking at early identification of PsA and predictors for outcome and quality of life and function. In her laboratory program, she has performed studies looking at susceptibility genes and biomarkers for disease expression. Dr. Gladman has collaborated in multi-centre studies using genome-wide association studies to identify genes for susceptibility to PsA. The PsA Program is the coordinating centre for the International Psoriatic Arthritis Research Team (IPART).
Dr. Gladman’s research in SLE has included studies describing new clinical features, development measurement tools, and the outcome and prognostic factors for this disease. In 1987, Dr. Gladman established SLICC (Systemic Lupus International Collaborating Clinics) and chaired it for 10 years. The SLICC Group developed a damage index for lupus and validated activity measures, which have allowed for the standardized assessment of SLE. Dr. Gladman has performed several studies identifying patients at risk for developing atherosclerotic disease and identifying methods for improved management and long-term outcomes in these patients.
Dr. Gladman’s research in SLE has included studies describing new clinical features, development measurement tools, and the outcome and prognostic factors for this disease. In 1987, Dr. Gladman established SLICC (Systemic Lupus International Collaborating Clinics) and chaired it for 10 years. The SLICC Group developed a damage index for lupus and validated activity measures, which have allowed for the standardized assessment of SLE. Dr. Gladman has performed several studies identifying patients at risk for developing atherosclerotic disease and identifying methods for improved management and long-term outcomes in these patients.
Research Interests
Papers共 1820 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Annals of the rheumatic diseasespp.ard-225613, (2024)
ARTHRITIS & RHEUMATOLOGYno. 2 (2024): 238-246
Rheumatology (Oxford, England) (2024)
Nature Reviews Rheumatologyno. 4 (2024): 232-240
Sherry Rohekar,Jordi Pardo Pardo,Reza Mirza,Sibel Z Aydin,Louis Bessette, Nicolas Richard,Dianne Mosher,Tristan Boyd,Jon Chan,Lihi Eder,Laura Passalent, Elie Karam,
Journal of the American Academy of Dermatology (2024)
Lupus Science and Medicineno. Suppl 2 (2024)
Fadi Kharouf,Dafna D Gladman
Expert review of clinical immunologypp.1-20, (2024)
Load More
Author Statistics
#Papers: 1810
#Citation: 89726
H-Index: 129
G-Index: 274
Sociability: 9
Diversity: 0
Activity: 13
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn